{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:57:00Z","timestamp":1779008220020,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12020-014-0489-2","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T09:50:59Z","timestamp":1417513859000},"page":"528-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Sara","family":"Ba\u00f1\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rosillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"P\u00e9rez-Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,29]]},"reference":[{"issue":"1","key":"489_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11904-013-0191-7","volume":"11","author":"AL Willig","year":"2014","unstructured":"A.L. Willig, E.T. Overton, Metabolic consequences of HIV: pathogenic insights. Curr. HIV\/AIDS Rep. 11(1), 35\u201344 (2014). doi: 10.1007\/s11904-013-0191-7","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"3","key":"489_CR2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/ciq158","volume":"52","author":"CN Dao","year":"2011","unstructured":"C.N. Dao, P. Patel, E.T. Overton, F. Rhame, S.L. Pals, C. Johnson, T. Bush, J.T. Brooks, Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin. Infect. Dis. 52(3), 396\u2013405 (2011). doi: 10.1093\/cid\/ciq158","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"489_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0b013e31821ae418","volume":"57","author":"OM Adeyemi","year":"2011","unstructured":"O.M. Adeyemi, D. Agniel, A.L. French, P.C. Tien, K. Weber, M.J. Glesby, M.C. Villacres, A. Sharma, D. Merenstein, E.T. Golub, W. Meyer, M. Cohen, Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J. Acquir. Immune Defic. Syndr. 57(3), 197\u2013204 (2011). doi: 10.1097\/QAI.0b013e31821ae418","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"9","key":"489_CR4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/aid.2011.0244","volume":"28","author":"M Cervero","year":"2012","unstructured":"M. Cervero, J.L. Agud, C. Garcia-Lacalle, V. Alcazar, R. Torres, J.J. Jusdado, S. Moreno Guillen, Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy. AIDS Res. Hum. Retrovir 28(9), 963\u2013971 (2012). doi: 10.1089\/AID.2011.0244","journal-title":"AIDS Res. Hum. Retrovir"},{"issue":"4","key":"489_CR5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jhep.2011.01.041","volume":"55","author":"B Terrier","year":"2011","unstructured":"B. Terrier, F. Carrat, G. Geri, S. Pol, L. Piroth, P. Halfon, T. Poynard, J.C. Souberbielle, P. Cacoub, Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J. Hepatol. 55(4), 756\u2013761 (2011). doi: 10.1016\/j.jhep.2011.01.041","journal-title":"J. Hepatol."},{"issue":"3","key":"489_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3851\/IMP1502","volume":"15","author":"TT Brown","year":"2010","unstructured":"T.T. Brown, G.A. McComsey, Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 15(3), 425\u2013429 (2010). doi: 10.3851\/IMP1502","journal-title":"Antivir Ther"},{"issue":"11","key":"489_CR7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1089\/aid.2008.0058","volume":"24","author":"Van Bout-Van Den","year":"2008","unstructured":"Van Den Bout-Van, C.J. Den Beukel, L. Fievez, M. Michels, F.C. Sweep, A.R. Hermus, M.E. Bosch, D.M. Burger, B. Bravenboer, P.P. Koopmans, A.J. Van Der Ven, Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retrovir 24(11), 1375\u20131382 (2008). doi: 10.1089\/aid.2008.0058","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"489_CR8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00198-009-1119-3","volume":"21","author":"HA Bischoff-Ferrari","year":"2010","unstructured":"H.A. Bischoff-Ferrari, A. Shao, B. Dawson-Hughes, J. Hathcock, E. Giovannucci, W.C. Willett, Benefit-risk assessment of vitamin D supplementation. Osteoporos. Int. 21(7), 1121\u20131132 (2010). doi: 10.1007\/s00198-009-1119-3","journal-title":"Osteoporos. Int."},{"issue":"5","key":"489_CR9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","volume":"79","author":"KC Chiu","year":"2004","unstructured":"K.C. Chiu, A. Chu, V.L. Go, M.F. Saad, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79(5), 820\u2013825 (2004)","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"489_CR10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0891988708327888","volume":"22","author":"DJ Llewellyn","year":"2009","unstructured":"D.J. Llewellyn, K.M. Langa, I.A. Lang, Serum 25-hydroxyvitamin D concentration and cognitive impairment. J. Geriatr. Psychiatry Neurol. 22(3), 188\u2013195 (2009). doi: 10.1177\/0891988708327888","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"1","key":"489_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11908-010-0144-x","volume":"13","author":"ET Overton","year":"2011","unstructured":"E.T. Overton, M.T. Yin, The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep 13(1), 83\u201393 (2011). doi: 10.1007\/s11908-010-0144-x","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"489_CR12","doi-asserted-by":"crossref","first-page":"e8770","DOI":"10.1371\/journal.pone.0008770","volume":"5","author":"S Mehta","year":"2010","unstructured":"S. Mehta, E. Giovannucci, F.M. Mugusi, D. Spiegelman, S. Aboud, E. Hertzmark, G.I. Msamanga, D. Hunter, W.W. Fawzi, Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 5(1), e8770 (2010). doi: 10.1371\/journal.pone.0008770","journal-title":"PLoS ONE"},{"issue":"10","key":"489_CR13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/QAD.0b013e328347f6f7","volume":"25","author":"JP Viard","year":"2011","unstructured":"J.P. Viard, J.C. Souberbielle, O. Kirk, J. Reekie, B. Knysz, M. Losso, J. Gatell, C. Pedersen, J.R. Bogner, J.D. Lundgren, A. Mocroft, Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25(10), 1305\u20131315 (2011). doi: 10.1097\/QAD.0b013e328347f6f7","journal-title":"AIDS"},{"issue":"9","key":"489_CR14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1089\/aid.2011.0325","volume":"28","author":"CK Kwan","year":"2012","unstructured":"C.K. Kwan, B. Eckhardt, J. Baghdadi, J.A. Aberg, Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York. AIDS Res Hum Retrovir 28(9), 1025\u20131032 (2012). doi: 10.1089\/AID.2011.0325","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"489_CR15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00198-013-2506-3","volume":"25","author":"JL Casado","year":"2014","unstructured":"J.L. Casado, S. Banon, R. Andres, M.J. Perez-Elias, A. Moreno, S. Moreno, Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients. Osteoporos Int 25(3), 1071\u20131079 (2014). doi: 10.1007\/s00198-013-2506-3","journal-title":"Osteoporos Int"},{"key":"489_CR16","doi-asserted-by":"crossref","unstructured":"Martinez, E., Jodar Gimeno, E., Reyes Garcia, R., Carpintero, P., Casado, J.L., Del Pino Montes, J., Domingo Pedrol, P., Estrada, V., Maalouf, J., Negredo, E., Ocampo, A., Munoz-Torres, M.: [Consensus statement: Recommendations for the management of metabolic bone disease in human immunodeficiency virus patients.]. Enfermedades infecciosas y microbiologia clinica (2013). doi: 10.1016\/j.eimc.2013.07.008","DOI":"10.1016\/j.eimc.2013.07.008"},{"issue":"1","key":"489_CR17","first-page":"7","volume":"20","author":"C Rio del","year":"2008","unstructured":"C. del Rio, Updated antiretroviral treatment guidelines from DHHS and EACS. AIDS Clin. Care 20(1), 7 (2008)","journal-title":"AIDS Clin. Care"},{"issue":"1","key":"489_CR18","first-page":"98","volume":"69","author":"G Dragovic","year":"2012","unstructured":"G. Dragovic, D. Jevtovic, Report on the 13th European AIDS conference\/EACS. Vojnosanitetski pregled. Milit Med Pharm Rev 69(1), 98\u201399 (2012)","journal-title":"Milit Med Pharm Rev"},{"issue":"5","key":"489_CR19","first-page":"461","volume":"86","author":"Rigueira Garcia","year":"2012","unstructured":"Rigueira Garcia, A.I.: [Recommendations on vitamin D and calcium supplements for adults in Spain]. Rev Esp Salud Publica 86(5), 461\u2013482 (2012). doi: 10.4321\/S1135-57272012000500002","journal-title":"Rev Esp Salud Publica"},{"key":"489_CR20","unstructured":"Torregrosa, J.V., Bover, J., Cannata Andia, J.: Spanish society of nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction. Nefrologia 31(Suppl 1), 1\u20132 (2011). doi: 10.3265\/Nefrologia.pre2011.Jan.10815"},{"issue":"7","key":"489_CR21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7), 1911\u20131930 (2011). doi: 10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"489_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocd.2011.03.004","volume":"14","author":"CJ Rosen","year":"2011","unstructured":"C.J. Rosen, J.C. Gallagher, The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2), 79\u201384 (2011). doi: 10.1016\/j.jocd.2011.03.004","journal-title":"J Clin Densitom"},{"issue":"2","key":"489_CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"S.J. Silverberg, E.M. Lewiecki, L. Mosekilde, M. Peacock, M.R. Rubin, Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2), 351\u2013365 (2009). doi: 10.1210\/jc.2008-1760","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"489_CR24","doi-asserted-by":"crossref","first-page":"e65785","DOI":"10.1371\/journal.pone.0065785","volume":"8","author":"AK Kasahara","year":"2013","unstructured":"A.K. Kasahara, R.J. Singh, A. Noymer, Vitamin D (25OHD) serum seasonality in the United States. PLoS ONE 8(6), e65785 (2013). doi: 10.1371\/journal.pone.0065785","journal-title":"PLoS ONE"},{"issue":"6","key":"489_CR25","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","volume":"90","author":"MF Holick","year":"2005","unstructured":"M.F. Holick, E.S. Siris, N. Binkley, M.K. Beard, A. Khan, J.T. Katzer, R.A. Petruschke, E. Chen, A.E. de Papp, Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90(6), 3215\u20133224 (2005). doi: 10.1210\/jc.2004-2364","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"489_CR26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/cid\/cir968","volume":"54","author":"PL Havens","year":"2012","unstructured":"P.L. Havens, C.B. Stephensen, R. Hazra, P.M. Flynn, C.M. Wilson, B. Rutledge, J. Bethel, C.G. Pan, L.R. Woodhouse, M.D. Van Loan, N. Liu, J. Lujan-Zilbermann, A. Baker, B.G. Kapogiannis, K. Mulligan, Adolescent Medicine trials network for, H.I.V.A.I.s.t.: Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis 54(7), 1013\u20131025 (2012). doi: 10.1093\/cid\/cir968","journal-title":"Clin Infect Dis"},{"issue":"2","key":"489_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1310\/hct1402-51","volume":"14","author":"V Giacomet","year":"2013","unstructured":"V. Giacomet, A. Vigano, V. Manfredini, C. Cerini, G. Bedogni, S. Mora, M. Borelli, D. Trabattoni, G.V. Zuccotti, Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial. HIV Clin Trials 14(2), 51\u201360 (2013). doi: 10.1310\/hct1402-51","journal-title":"HIV Clin Trials"},{"issue":"4","key":"489_CR28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3851\/IMP1983","volume":"17","author":"CT Longenecker","year":"2012","unstructured":"C.T. Longenecker, C.O. Hileman, T.L. Carman, A.C. Ross, S. Seydafkan, T.T. Brown, D.E. Labbato, N. Storer, V. Tangpricha, G.A. McComsey, Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 17(4), 613\u2013621 (2012). doi: 10.3851\/IMP1983","journal-title":"Antivir Ther"},{"key":"489_CR29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/1471-2334-13-577","volume":"13","author":"RJ Piso","year":"2013","unstructured":"R.J. Piso, M. Rothen, J.P. Rothen, M. Stahl, C. Fux, Per oral substitution with 300000\u00a0IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients. BMC Infect. Dis. 13, 577 (2013). doi: 10.1186\/1471-2334-13-577","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"489_CR30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","volume":"95","author":"L Tripkovic","year":"2012","unstructured":"L. Tripkovic, H. Lambert, K. Hart, C.P. Smith, G. Bucca, S. Penson, G. Chope, E. Hypponen, J. Berry, R. Vieth, S. Lanham-New, Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am. J. Clin. Nutr. 95(6), 1357\u20131364 (2012). doi: 10.3945\/ajcn.111.031070","journal-title":"Am. J. Clin. Nutr."},{"key":"489_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1756-0500-5-204","volume":"5","author":"M Etminani-Esfahani","year":"2012","unstructured":"M. Etminani-Esfahani, H. Khalili, S. Jafari, A. Abdollahi, S. Dashti-Khavidaki, Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz. BMC Res Notes 5, 204 (2012). doi: 10.1186\/1756-0500-5-204","journal-title":"BMC Res Notes"},{"issue":"6","key":"489_CR32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3945\/ajcn.111.031427","volume":"95","author":"KD Cashman","year":"2012","unstructured":"K.D. Cashman, K.M. Seamans, A.J. Lucey, E. Stocklin, P. Weber, M. Kiely, T.R. Hill, Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am. J. Clin. Nutr. 95(6), 1350\u20131356 (2012). doi: 10.3945\/ajcn.111.031427","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"489_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jbmr.551","volume":"27","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"H.A. Bischoff-Ferrari, B. Dawson-Hughes, E. Stocklin, E. Sidelnikov, W.C. Willett, J.O. Edel, H.B. Stahelin, S. Wolfram, A. Jetter, J. Schwager, J. Henschkowski, A. von Eckardstein, A. Egli, Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res 27(1), 160\u2013169 (2012). doi: 10.1002\/jbmr.551","journal-title":"J Bone Miner Res"},{"issue":"1","key":"489_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"N.E. Cusano, S.J. Silverberg, J.P. Bilezikian, Normocalcemic primary hyperparathyroidism. J Clin Densitom 16(1), 33\u201339 (2013). doi: 10.1016\/j.jocd.2012.12.001","journal-title":"J Clin Densitom"},{"issue":"10","key":"489_CR35","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"S.J. Silverberg, B.L. Clarke, M. Peacock, F. Bandeira, S. Boutroy, N.E. Cusano, D. Dempster, E.M. Lewiecki, J.M. Liu, S. Minisola, L. Rejnmark, B.C. Silva, M.D. Walker, J.P. Bilezikian, Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99(10), 3580\u20133594 (2014). doi: 10.1210\/jc.2014-1415","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"489_CR36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357(3), 266\u2013281 (2007). doi: 10.1056\/NEJMra070553","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"489_CR37","doi-asserted-by":"crossref","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","volume":"88","author":"G Jones","year":"2008","unstructured":"G. Jones, Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88(2), 582S\u2013586S (2008)","journal-title":"Am J Clin Nutr"},{"key":"489_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-6405-7-40","volume":"7","author":"A Conesa-Botella","year":"2010","unstructured":"A. Conesa-Botella, E. Florence, L. Lynen, R. Colebunders, J. Menten, R. Moreno-Reyes, Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther 7, 40 (2010). doi: 10.1186\/1742-6405-7-40","journal-title":"AIDS Res Ther"},{"issue":"1","key":"489_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/aid.2010.0081","volume":"27","author":"J Fox","year":"2011","unstructured":"J. Fox, B. Peters, M. Prakash, J. Arribas, A. Hill, C. Moecklinghoff, Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res. Hum. Retrovir 27(1), 29\u201334 (2011). doi: 10.1089\/aid.2010.0081","journal-title":"AIDS Res. Hum. Retrovir"},{"issue":"12","key":"489_CR40","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32833c3281","volume":"24","author":"T Welz","year":"2010","unstructured":"T. Welz, K. Childs, F. Ibrahim, M. Poulton, C.B. Taylor, C.F. Moniz, F.A. Post, Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 24(12), 1923\u20131928 (2010). doi: 10.1097\/QAD.0b013e32833c3281","journal-title":"AIDS"},{"issue":"11","key":"489_CR41","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1210\/jc.2012-2600","volume":"97","author":"PL Havens","year":"2012","unstructured":"P.L. Havens, K. Mulligan, R. Hazra, P. Flynn, B. Rutledge, M.D. Van Loan, J. Lujan-Zilbermann, B.G. Kapogiannis, C.M. Wilson, C.B. Stephensen, Adolescent Medicine Trials Network for, H.I.V.A.I.S.T.: Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000\u00a0IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab 97(11), 4004\u20134013 (2012). doi: 10.1210\/jc.2012-2600","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"489_CR42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/oby.2007.23","volume":"16","author":"K Rajakumar","year":"2008","unstructured":"K. Rajakumar, J.D. Fernstrom, M.F. Holick, J.E. Janosky, S.L. Greenspan, Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children. Obesity 16(1), 90\u201395 (2008). doi: 10.1038\/oby.2007.23","journal-title":"Obesity"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0489-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0489-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T22:08:17Z","timestamp":1566079697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0489-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,29]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0489-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,29]]}}}